Back HIV Basic Science Immune Response

Immune Response to HIV

Dendritic Cell Therapeutic Vaccine Helps Immune Cells Control HIV Replication

A therapeutic vaccine made from dendritic cells primed with heat-inactivated HIV stimulated immune cells to mount a response against the virus without it infecting and killing them, according to a study described in the January 2, 2013, issue of Science Translational Medicine.

alt

Read more:

Immune Activation Raised HIV Risk in CAPRISA Trial, but Some Develop Protective Antibodies

Women in the CAPRISA 004 vaginal gel trial who showed evidence of prior immune activation had an increased likelihood of becoming infected with HIV, researchers recently reported. Another CAPRISA analysis found that 2 women exhibitedbroadly cross-neutralizing antibodies targeting a newly emergent antigen on HIV's envelope -- a discovery that could advance vaccine research.alt

Read more:

Immediate Antiretroviral Therapy Reduces HIV Infection of Resting CD4 T-Cells

Starting antiretroviral therapy (ART) during the acute phase of HIV infection appears to reduce the number of latently infected resting CD4 T-cells in most people, but this may not be the case for individuals with very few initially infected cells, according to a study published in the May 29, 2012, advance online edition of Proceedings of the National Academy of Sciences.alt

Read more:

Researchers Shed Light on Natural Control of HIV

Certain T-cell antigen receptor types are associated with greater response to HIV, which may help explain how a small proportion of people are able to naturally control HIV without antiretroviral therapy, according to a report in the June 10, 2012, advance online edition of Nature Immunology.alt

Read more:

More Gut Th17 Cells Linked to Better Control of HIV-like Virus in Monkeys

Rhesus macaque monkeys that had a larger number of a specific type of helper T-cells -- known as TH17 cells -- in their blood and intestinal tissue at the time of infection with SIV (a monkey virus related to HIV) had lower viral load set-points, according to a study published in the May 30, 2012, issue of Science Translational Medicine.alt

Read more: